Related Experiment Video
Updated: Jul 26, 2025

Selection-dependent and Independent Generation of CRISPR/Cas9-mediated Gene Knockouts in Mammalian Cells
Published on: June 16, 2017
Generation of a homozygous RANGRF knockout hiPSC line by CRISPR/Cas9 system
Meiling Jiang1, Chengcheng Tang1, Xian Luo1
1Guangdong Provincial Key Laboratory of Large Animal Models for Biomedicine, South China Institute of Large Animal Models for Biomedicine, School of Biotechnology and Health Science, Wuyi University, Jiangmen, China.
Abstract:
The RAN Guanine Nucleotide Release Factor (RANGRF) gene encodes the protein MOG1, which binds to Nav1.5 and facilitates its transport to the cell membrane. Nav1.5 mutations have been linked to various cardiac arrhythmias and cardiomyopathy. To investigate the role of RANGRF in this process, we utilized the CRISPR/Cas9 gene editing system to generate a homozygous RANGRF knockout hiPSC line. The availability of the cell line will prove to be an invaluable asset in the study of disease mechanisms and the testing of gene therapies for cardiomyopathy.
Insights
Researchers created a RAN Guanine Nucleotide Release Factor (RANGRF) knockout cell line. This new model aids in studying cardiomyopathy and testing gene therapies for heart conditions.
Area of Science:
- Cardiovascular Biology
- Molecular Genetics
- Cell Biology
Background:
- The RAN Guanine Nucleotide Release Factor (RANGRF) gene encodes the MOG1 protein, crucial for Nav1.5 transport.
- Nav1.5 channel dysfunction due to mutations is associated with cardiac arrhythmias and cardiomyopathy.
- Understanding RANGRF's role is vital for cardiac disease research.
Purpose of the Study:
- To investigate the function of RANGRF in the context of cardiac health.
- To generate a cellular model for studying RANGRF-related cardiac pathologies.
- To create a tool for evaluating potential gene therapies for cardiomyopathy.
Main Methods:
- CRISPR/Cas9 gene editing technology was employed.
- A homozygous RANGRF knockout human induced pluripotent stem cell (hiPSC) line was generated.
- The resulting cell line serves as a disease model.
Main Results:
- A functional RANGRF knockout hiPSC line was successfully established.
- This cell line provides a platform for mechanistic studies.
- The model is suitable for screening gene therapy candidates.
Conclusions:
- The RANGRF knockout hiPSC line is a significant resource for cardiac research.
- This model will advance the understanding of cardiomyopathy.
- It facilitates the development and testing of novel therapeutic strategies for heart disease.

